Same-day gonorrhea and chlamydia testing for young people
Clinical and Implementation Outcomes of a Point of Care Sexually Transmitted Infection Testing Strategy to Improve HIV Prevention Service Delivery in Adolescents
This project will test whether point-of-care gonorrhea and chlamydia testing helps improve HIV testing and same-day PrEP counseling and prescriptions for 16–24-year-olds in pediatric clinics.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 6460 (estimated) |
| Ages | 16 Years to 24 Years |
| Sex | All |
| Sponsor | Icahn School of Medicine at Mount Sinai Academic / other |
| Locations | 1 site (Philadelphia, Pennsylvania) |
| Trial ID | NCT06844045 on ClinicalTrials.gov |
What this trial studies
The trial compares clinical and implementation outcomes between adolescents receiving point-of-care (POCT) gonorrhea/chlamydia testing and those receiving standard laboratory-based testing across three clinics in a large pediatric health system. Clinical outcomes include rates of HIV testing, PrEP counseling, and PrEP prescriptions, while implementation outcomes include feasibility, acceptability, and appropriateness. The design is a pragmatic, non-randomized comparison embedded in routine care to reflect real-world conditions. Investigators hypothesize POCT will increase opportunities for clinician-patient counseling, reduce loss to follow-up, and enable same-day HIV prevention service delivery.
Who should consider this trial
Good fit: Adolescents and young adults aged 16 to 24 who are receiving gonorrhea/chlamydia testing and who do not have known HIV and are not currently on PrEP.
Not a fit: Patients with known HIV infection or who already have an active PrEP prescription are excluded and would not receive direct benefit from this intervention.
Why it matters
Potential benefit: If successful, the approach could enable more same-day HIV prevention services and faster PrEP starts for youth, reducing missed opportunities for prevention.
How similar studies have performed: Point-of-care STI testing has improved time-to-diagnosis and treatment in other settings, but its specific effect on youth HIV testing and PrEP delivery remains less well established.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: \- Patients age 16-24 years receiving POCT or lab-based GC/CT testing Exclusion Criteria: \- Patients with known HIV or active PrEP prescriptions.
Where this trial is running
Philadelphia, Pennsylvania
- Children's Hospital of Philadelphia — Philadelphia, Pennsylvania, United States (Recruiting)
Study contacts
- Principal investigator: Sarah Wood, MD, MSHP — Mount Sinai Adolescent Health Center
- Study coordinator: Naomi Pressman, MS, RD
- Email: naomi.pressman@mountsinai.org
- Phone: (212) 731-7810
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.